Publications by authors named "Yundong Fu"

Claim this Profile
5
53BP1 regulates p53-E2F7-dependent transcriptional gene repression and participates in the Fanconi anemia pathway.
Yundong Fu, Wei Wu, Maosha Zhang, Zeming Rong, Bao Lin

Cell Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azocarboxamide-enabled enantioselective regiodivergent unsymmetrical 1,2-diaminations.
Yun-Dong Fu, Han Zhang, Bei-Bei Li, Lihua Huang, Xiao Xiao

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
Yazhen You, Yundong Fu, Mingjie Huang, Dandan Shen, Bing Zhao

Int J Mol Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of IL-6-IL-27 Complex in Host Antiviral Immune Response.
Qi Zuo, Zhikui Cheng, Guoqing Zhang, Yongfang Xia, Gang Xu, Yundong Fu

J Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of new tranylcypromine derivatives as highly potent LSD1 inhibitors.
Ming-Jie Huang, Jia-Wen Guo, Yun-Dong Fu, Ya-Zhen You, Wen-Yu Xu

Bioorg Med Chem Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting histone demethylase KDM5B for cancer treatment.
Yun-Dong Fu, Ming-Jie Huang, Jia-Wen Guo, Ya-Zhen You, Hong-Min Liu

Eur J Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of [1,2,3]triazolo[4,5-]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors.
Zhenzhen Liu, Taoqian Zhao, Zhonghua Li, Kai Sun, Yundong Fu

Acta Pharm Sin B· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent hydrazone derivatives targeting esophageal cancer cells.
Ling-Yu Li, Jia-Di Peng, Wenjuan Zhou, Hui Qiao, Xin Deng, Yun-Dong Fu

Eur J Med Chem· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation.
Kai Sun, Jia-Di Peng, Feng-Zhi Suo, Ting Zhang, Yun-Dong Fu

Bioorg Med Chem Lett· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis